Össur hf. - Other information disclosed according to the rules of the Exchange

Ossur Hf : Össur announces efficiency initiatives

Announcement no. 68/2017
Reykjavík, 25 September 2017


Össur announces efficiency initiatives

At   the  Capital  Markets  Day  in  Copenhagen  on  27 September  2017, Össur's
management will elaborate on growth, innovation, and new efficiency initiatives.

Össur's  sales have grown at a 22% compound annual growth rate since the Company
was  listed in 1999. This growth has been driven by a combination of organic and
acquired  growth, where the  acquisitions of Touch  Bionics and Medi Prosthetics
represent  the latest additions to the Össur business. Össur's profitability has
grown at a similar rate with a continuous focus on operational improvements.

Össur   has   identified   further   opportunities  to  increase  efficiency  by
consolidating  and  simplifying  its  operations  to  better  leverage  its  key
strategic   locations.   Consequently,  Össur  has  initiated  three  efficiency
initiatives in the areas of Manufacturing, Distribution, and Sourcing to support
further profitable growth.

The  initiatives will be implemented over the next three years where annual cost
savings  are expected to  materialize gradually and  amount to USD 10 million in
2020. Total  implementation  costs  are  expected  to  amount to USD 15 million,
hereof   approximately   USD   3 million  in  the  third  quarter  of  2017. The
implementation  costs  will  be  expensed  as  special items over the three-year
period.  In addition, total capital expenditures  related to the initiatives are
expected to be around USD 4 million.

Össur  aims to further strengthen  its innovation by investing  a portion of the
realized savings in research and development.

These  measures do not impact  the full year guidance  of 2017 as Össur provides
guidance on EBITDA margin before special items.

For further information
Presentation material with additional information will be published just before
the Capital Markets Day begins and will be made available on Össur's website:
www.ossur.com/investors.

Contact details

Jon Sigurdsson, President & CEO                                    +354 515 1300

Sveinn Solvason, CFO                                        +354 515 1300

David    Hreidarsson,   Investor   Relations                                +354
515 1380                   dhreidarsson@ossur.com


Össur corporate announcements by e-mail
If you wish to receive Össur e-mail alerts, please register on our website:
www.ossur.com/investors.




About Össur
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps
people live a life without limitations.  Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports, prosthetic limbs and compression therapy.  A
recognized "Technology Pioneer", Össur invests significantly in research and
product development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are further
empowered via Össur's educational programs and business solutions.
Headquartered in Iceland, Össur has major operations in the Americas, EMEA and
APAC, with additional distributors worldwide. www.ossur.com.

Forward-looking statements
This press release includes "forward-looking statements" which involve risks and
uncertainties that could cause actual results to differ materially from results
expressed or implied by these statements. Össur hf. undertakes no obligation and
does not intend to update these forward-looking statements to reflect events or
circumstances occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this press release. All forward-looking statements are qualified in
their entirety by this cautionary statement.


[]

Bifogade filer:

Össur announces efficiency initiatives.pdf